MSLN and mesothelioma: Among the several discovered biomarker candidates, mesothelin, a cell-surface membrane-bound glycophosphatidylinositol (GPI)-anchored protein, is the only molecule approved by the Food and Drug Administration for clinical use in mesothelioma (8–11).